Company Filing History:
Years Active: 2019
Title: Innovator Jan Søndergaard-Andersen: Pioneering Allergen Dosage Forms in Hillerød, DK
Introduction: Jan Søndergaard-Andersen is an innovative inventor based in Hillerød, Denmark, recognized for his contributions to the field of allergen pharmaceuticals. With a focus on creating efficient and effective dosage forms, he has made significant strides in improving the delivery of allergen-based treatments.
Latest Patents: Jan holds a notable patent for an "Allergen Dosage Form." This invention introduces allergen-containing pharmaceutical products, particularly focusing on fast-dispersing solid dosage forms that are suitable for oromucosal administration. The patent details the formulation of non-compressed solid dosage forms that utilize matrices such as gelatine, starch, and mannitol to enhance the delivery and efficacy of allergens. Methods for producing these dosage forms are also outlined, demonstrating Jan's dedication to advancing allergen treatments.
Career Highlights: Currently, Jan is affiliated with Alk-Abelló A/S, a key player in allergy immunotherapy. His work at the company showcases his commitment to enhancing patient care through innovative pharmaceutical solutions. His sole patent reflects his ability to address significant needs within the allergy treatment landscape.
Collaborations: Jan collaborates with esteemed colleagues, including Henrik Hugo Jacobi and Annette Rømmelmayer Lundegaard. Together, they contribute to the field of allergen research and drive forward-thinking approaches in pharmaceutical development.
Conclusion: Jan Søndergaard-Andersen exemplifies the spirit of innovation within the pharmaceutical industry. Through his patent for fast-dispersing allergen dosage forms and his work at Alk-Abelló A/S, he continues to shape the future of allergy treatment, improving the lives of many patients. His dedication to research and development highlights the importance of innovation in advancing healthcare solutions.